These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 28401430)
1. Bilateral Effects of Excipients on Protein Stability: Preferential Interaction Type of Excipient and Surface Aromatic Hydrophobicity of Protein. Wen L; Zheng X; Wang X; Lan H; Yin Z Pharm Res; 2017 Jul; 34(7):1378-1390. PubMed ID: 28401430 [TBL] [Abstract][Full Text] [Related]
2. Preferential interactions between protein and arginine: effects of arginine on tertiary conformational and colloidal stability of protein solution. Wen L; Chen Y; Liao J; Zheng X; Yin Z Int J Pharm; 2015 Jan; 478(2):753-61. PubMed ID: 25529432 [TBL] [Abstract][Full Text] [Related]
3. Molecular Computations of Preferential Interaction Coefficients of IgG1 Monoclonal Antibodies with Sorbitol, Sucrose, and Trehalose and the Impact of These Excipients on Aggregation and Viscosity. Cloutier T; Sudrik C; Mody N; Sathish HA; Trout BL Mol Pharm; 2019 Aug; 16(8):3657-3664. PubMed ID: 31276620 [TBL] [Abstract][Full Text] [Related]
4. Trehalose Monooleate: A Potential Antiaggregation Agent for Stabilization of Proteins. Kale SS; Akamanchi KG Mol Pharm; 2016 Dec; 13(12):4082-4093. PubMed ID: 27726389 [TBL] [Abstract][Full Text] [Related]
5. Machine Learning Models of Antibody-Excipient Preferential Interactions for Use in Computational Formulation Design. Cloutier TK; Sudrik C; Mody N; Sathish HA; Trout BL Mol Pharm; 2020 Sep; 17(9):3589-3599. PubMed ID: 32794710 [TBL] [Abstract][Full Text] [Related]
6. Understanding the Role of Preferential Exclusion of Sugars and Polyols from Native State IgG1 Monoclonal Antibodies and its Effect on Aggregation and Reversible Self-Association. Sudrik CM; Cloutier T; Mody N; Sathish HA; Trout BL Pharm Res; 2019 May; 36(8):109. PubMed ID: 31127417 [TBL] [Abstract][Full Text] [Related]
7. Computational Characterization of Antibody-Excipient Interactions for Rational Excipient Selection Using the Site Identification by Ligand Competitive Saturation-Biologics Approach. Jo S; Xu A; Curtis JE; Somani S; MacKerell AD Mol Pharm; 2020 Nov; 17(11):4323-4333. PubMed ID: 32965126 [TBL] [Abstract][Full Text] [Related]
8. Surface Composition and Formulation Heterogeneity of Protein Solids Produced by Spray Drying. Wilson NE; Mutukuri TT; Zemlyanov DY; Taylor LS; Topp EM; Zhou QT Pharm Res; 2019 Dec; 37(1):14. PubMed ID: 31873808 [TBL] [Abstract][Full Text] [Related]
9. The surface characterisation and comparison of two potential sub-micron, sugar bulking excipients for use in low-dose, suspension formulations in metered dose inhalers. James J; Crean B; Davies M; Toon R; Jinks P; Roberts CJ Int J Pharm; 2008 Sep; 361(1-2):209-21. PubMed ID: 18577435 [TBL] [Abstract][Full Text] [Related]
10. Freeze-Drying of L-Arginine/Sucrose-Based Protein Formulations, Part 2: Optimization of Formulation Design and Freeze-Drying Process Conditions for an L-Arginine Chloride-Based Protein Formulation System. Stärtzel P; Gieseler H; Gieseler M; Abdul-Fattah AM; Adler M; Mahler HC; Goldbach P J Pharm Sci; 2015 Dec; 104(12):4241-4256. PubMed ID: 26422647 [TBL] [Abstract][Full Text] [Related]
11. Rational approach for design and evaluation of anti-aggregation agents for protein stabilization: A case study of trehalose phenylalaninate. Kale SS; Akamanchi KG Int J Pharm; 2017 May; 524(1-2):215-225. PubMed ID: 28365391 [TBL] [Abstract][Full Text] [Related]
13. Protein Aggregation and Performance Optimization Based on Microconformational Changes of Aromatic Hydrophobic Regions. Wen L; Lyu M; Xiao H; Lan H; Zuo Z; Yin Z Mol Pharm; 2018 Jun; 15(6):2257-2267. PubMed ID: 29694051 [TBL] [Abstract][Full Text] [Related]
14. Excipients differentially influence the conformational stability and pretransition dynamics of two IgG1 monoclonal antibodies. Thakkar SV; Joshi SB; Jones ME; Sathish HA; Bishop SM; Volkin DB; Middaugh CR J Pharm Sci; 2012 Sep; 101(9):3062-77. PubMed ID: 22581714 [TBL] [Abstract][Full Text] [Related]
15. Characterization of antibody-polyol interactions by static light scattering: implications for physical stability of protein formulations. Abbas SA; Sharma VK; Patapoff TW; Kalonia DS Int J Pharm; 2013 May; 448(2):382-9. PubMed ID: 23583711 [TBL] [Abstract][Full Text] [Related]
16. Solubilization of aromatic and hydrophobic moieties by arginine in aqueous solutions. Li J; Garg M; Shah D; Rajagopalan R J Chem Phys; 2010 Aug; 133(5):054902. PubMed ID: 20707549 [TBL] [Abstract][Full Text] [Related]
17. Local dynamics and their alteration by excipients modulate the global conformational stability of an lgG1 monoclonal antibody. Thakkar SV; Kim JH; Samra HS; Sathish HA; Bishop SM; Joshi SB; Volkin DB; Middaugh CR J Pharm Sci; 2012 Dec; 101(12):4444-57. PubMed ID: 23060088 [TBL] [Abstract][Full Text] [Related]
18. Role of trehalose in moisture-induced aggregation of bovine serum albumin. Jain NK; Roy I Eur J Pharm Biopharm; 2008 Aug; 69(3):824-34. PubMed ID: 18407479 [TBL] [Abstract][Full Text] [Related]
19. Molecular computations of preferential interactions of proline, arginine.HCl, and NaCl with IgG1 antibodies and their impact on aggregation and viscosity. Cloutier TK; Sudrik C; Mody N; Hasige SA; Trout BL MAbs; 2020; 12(1):1816312. PubMed ID: 32938318 [TBL] [Abstract][Full Text] [Related]